Skip to product information
1 of 2

MoInlycke

Granulox Haemoglobin Based Spray - Case of 6

Granulox Haemoglobin Based Spray - Case of 6

Regular price £1,402.79 inc.VAT
£1,168.99 ex.VAT
Regular price £0.00 Sale price £1,402.79 inc.VAT
£1,168.99 ex.VAT
Sale Sold out

AVAILABLE TO BACKORDER - Buy now for despatch when stock arrives.

SKU: 360001

Shipping

FREE STANDARD SHIPPING available on all orders over £25 EX VAT.

Next working day - available until 8pm Monday to Friday
Weekend despatchavailable until 12pm Sunday for MONDAY delivery (Next working day)
Sat and Sunday delivery service - available until 5pm Friday.

Why buy from Medisave?

Medisave supplies health professionals, business and home users.

  • Credit card, PayPal and Amazon Payments accepted
  • Free delivery over £25 ex VAT
  • NHS, school or company purchase order - email accounts@medisave.co.uk
  • Laser engraving
  • Delivery to private or commercial addresses
  • Google Certified Shop
  • Registered with the Medicines and Healthcare products Regulatory Agency (MHRA)
  • ISO9001 quality management system + ISO 140001 environmental
  • Established 1999

Need some advice? Speak to our friendly team on 0800 804 6447

View full details

Granulox® is an oxygenating spray for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, arterial leg ulcers, and mixed leg ulcers for the secondary healing of surgical wounds and pressure sores. It can also be used on healing of sloughy and infected wounds.

When Granulox is sprayed on a wound, highly purified haemoglobin is released. This binds with oxygen from the environment and diffuses through the wound exudate, and the haemoglobin supplies the base of the wound topically with oxygen. The oxygen supply to the base of the wound supports wound healing and patient outcomes.

A convenient spray application makes Granulox a portable and easy-to-use adjunct to standard of care wound treatment. Granulox can be applied when the wound dressing is changed, and at least every three days for optimal results.

Studies report that using Granulox results in shorter healing time, reduced pain scores and total cost savings for healthcare providers compared to standard of care.

  • Twice as many chronic wounds healed at 8–16 weeks compared to standard of care
  • Time to heal diabetic foot ulcers 50% shorter than with standard of care
  • Treatment costs in diabetic foot ulcers at least 40% lower than with standard of care
  • More than 70% of patients reported lower average pain scores at four weeks than with standard of care in chronic wounds
  • 99% less slough in chronic wounds after 4 weeks compared to 33% with standard of care